Longevity clinic marketing: anti-aging claims, off-label drugs and biological age tests

A longevity clinic sells to people who feel fine and want to stay that way. The services vary: extended lab panels, body composition and fitness testing, coaching on sleep, exercise and diet, prescriptions, and memberships that bundle it all. What ties them together in the ad is a promise about time: slow aging, reverse your biological age, add healthy years. That promise is the part a regulator reads first, because it is a health benefit claim about an outcome no single visit can show.

Two related topics have their own guides and are not repeated here. Compounded peptides and FDA bulk drug substance categories are in our peptide therapy clinic marketing guide. The cash-pay and membership model, lab panels, telehealth across state lines and supplement sales are in our functional medicine practice marketing guide. This guide covers the claims that are specific to longevity marketing: anti-aging and lifespan wording, approved drugs prescribed for unapproved uses, and biological age tests.

Why longevity claims draw scrutiny

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 makes it unlawful to disseminate a false advertisement to induce the purchase of drugs, devices or services. The FTC Health Products Compliance Guidance explains how the agency applies those laws to health claims, and three of its points matter directly for a longevity clinic:

• Claims about the health benefits of a product must meet the basic substantiation standard of “competent and reliable scientific evidence”, and the guidance says that, as a general matter, substantiation of health-related benefits will need to be in the form of randomized, controlled human clinical testing.
• When an ad lends itself to more than one reasonable interpretation, the advertiser is responsible for substantiating each interpretation.
• Anecdotal evidence about the individual experiences of consumers, including surveys of consumer experiences, is never sufficient to substantiate claims about the effects of a health product, and the guidance adds that a healthcare practitioner’s observation about the effect of a health product on patients is anecdotal as well.

The last point is the one that catches clinics. A founder who has seen patients feel more energetic, sleep better or post better lab numbers has observations, not substantiation. Those observations can guide care inside the clinic. They cannot carry an ad that promises the same to strangers.

Anti-aging, reverse aging and lifespan wording

Longevity language falls into a few kinds of claim, and each one carries a different burden. Read each line the way a healthy 45-year-old scrolling past it would:

• “Anti-aging” or “slow aging” claims that a service changes the aging process itself. That is a health benefit claim about a long-term outcome, and no clinic visit can show it happened.
• “Reverse your biological age” or “turn back the clock” claims that the body is measurably younger after treatment. It rests on a lab score, which raises the biomarker questions covered below.
• “Add years to your life”, “live to 100” or “extend your lifespan” are survival claims. They need evidence that the service changes how long people live, not only that it changes a marker.
• “Prevent disease” or “stop age-related decline” are disease prevention claims, and naming a disease such as dementia or heart disease raises the stakes further.
• “Optimize”, “peak performance” or “feel 20 years younger” sound softer but still imply a measurable result. Each reasonable reading of the phrase has to be supported.

Plain descriptions of what the clinic does carry far less risk and still attract the right patients: which tests are run, who reviews them, how long a visit is, what the follow-up plan includes, and what the price covers. “A physician-led program focused on sleep, exercise, nutrition and preventive care, with a written plan after each review” makes no claim about the calendar. “Reverse aging in 90 days” does.

Approved drugs used for unapproved purposes

A longevity program may include drugs that are FDA approved for a specific condition, prescribed for a goal such as healthy aging. That is an unapproved, or “off-label”, use. FDA’s consumer page on the subject explains both sides:

• From the FDA perspective, once a drug is approved, healthcare providers generally may prescribe it for an unapproved use when they judge that it is medically appropriate for their patient.
• When a drug is used for an unapproved use, FDA writes, the patient should remember that FDA has not determined that the drug is safe and effective for that use.
• FDA suggests patients ask what the drug is approved for, what scientific studies support the unapproved use, what the potential benefits and risks are, and whether there are clinical trials they could join.

A prescriber’s freedom to make that judgment for one patient is not a license to advertise the use to the public. Once a clinic’s website or ad says a drug slows aging, extends life or protects against age-related disease, the clinic is making a health benefit claim that it must substantiate under the FTC standard above. The FDA approval for a different condition does not substantiate it.

The safer approach for marketing pages:

• Do not name prescription drugs in ads or on service pages as longevity treatments, and do not list doses, schedules or “stacks”. Prescribing decisions belong in a visit.
• Do not describe any drug as “FDA approved for longevity” or “FDA approved for anti-aging”. The National Institute on Aging notes that geroscience drug development raises novel issues for FDA review, including defining the indication and the evidence needed to support a claim.
• If the clinic may discuss off-label prescribing in a visit, say so plainly: that the clinician reviews what a drug is approved for, what the evidence for another use is, and the risks, and that the patient decides with that information.
• Use the same care for supplements, hormones and compounded products. Each one sold or promoted by the clinic carries its own claims.

Biological age tests are lab claims

Biological age scores, epigenetic clocks and similar panels appear in longevity marketing because they turn a vague promise into a number. That makes the score a concrete, checkable claim, and it needs care.

First, the test itself. CMS says it regulates laboratory testing performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). Confirm that every lab the clinic uses for patient testing holds the CLIA certificate that fits the tests it runs, and that results are returned through a clinician when that is what your state rules call for. Who may order a test and receive a result directly is covered in our direct-to-consumer lab testing marketing guide.

Second, what the score means. A biological age number is an estimate from a model, and a change in that number is a change in a marker. The NIA page on FDA review of geroscience drug programs notes that FDA has accepted effects on a limited number of surrogate endpoints as a basis for claims, based on specific criteria. An ad that says a lower score means a longer or healthier life is treating the score as proof of an outcome, and that is a separate claim to substantiate.

Before a biological age test appears in marketing, check these points:

• Describe it accurately: what it measures, which model produces the score, and that it is an estimate.
• Do not present the score as a diagnosis or as a prediction of when a person will become ill or die.
• Do not claim a treatment “reversed” or “lowered” biological age unless the evidence supports both the measurement and the meaning given to it.
• Say whether results vary between tests or between samples, if the lab’s own materials say so.
• Tell patients who will review the result with them and what happens next.

Memberships and prices

When a longevity program is sold as a membership or package and you advertise a price, say what it includes: visits, tests, prescriptions or not, coaching and follow-up. Memberships that renew automatically online carry federal disclosure, consent and cancellation rules; see our guide to membership auto-renewal rules. Self-pay patients may be entitled to a good faith estimate; see our guide to good faith estimates for self-pay patients. Financing offers have their own rules, covered in our guide to advertising patient financing.

A membership described as “a lifetime of healthy years” or “invest in a longer life” carries a lifespan claim inside the price. Describe the membership by what it delivers, not by what it promises to add to the patient’s life.

Founders, creators and patient stories

Longevity marketing can lean on personalities: a founder who shares their own protocol, creators who post their test results, patients who describe how they feel. Each of these is an endorsement under the FTC Endorsement Guides. Under 16 CFR 255.2(a), the advertiser must be able to substantiate claims made through an endorsement as if it had made them directly. Under 16 CFR 255.2(b), an ad that presents one person’s experience on a key point is likely to be read as showing what others will achieve, and without substantiation that the result is representative, the ad should clearly disclose the generally expected results.

Under 16 CFR 255.5, a connection between an endorser and the seller that might materially affect the weight or credibility of the endorsement must be disclosed clearly and conspicuously. That covers creators paid in cash, free memberships or free tests, and affiliate codes. Our healthcare influencer marketing guide covers the mechanics.

A patient’s story, test results or before-and-after numbers are protected health information when the clinic holds them, and 45 CFR 164.508 generally requires written authorization before using them in marketing; see our guide to patient testimonials and before-and-after photos. Keep intake, lab and booking pages free of ad tracking tools as well; our guide to tracking pixels on practice websites explains why.

Illustration: two ways to advertise a longevity program

Illustration: [Clinic name] runs an ad that reads “Reverse your biological age by 10 years. Our anti-aging protocol uses the same drugs the experts take. Live longer, starting today.” The landing page shows the founder’s own biological age score, a list of named prescription drugs with doses, and three patient quotes about feeling younger. Each line carries a claim the clinic cannot support with the evidence the FTC describes, the drug list promotes unapproved uses, and the patient quotes have no disclosure of what patients generally experience.

Illustration: [Clinic name] runs an ad that reads “A physician-led prevention program. Extended labs, fitness testing and a written plan, reviewed with you every quarter.” The landing page lists what the membership includes and costs, explains that any prescription is a clinical decision made in a visit after reviewing approved uses, evidence and risks, describes the biological age test as an estimate from a named type of model, and states the renewal and cancellation terms. It makes no promise about lifespan.

Checklist before a longevity campaign goes live

• No “anti-aging”, “reverse aging”, “add years” or “prevent disease” promises unless the evidence meets the FTC standard for each reasonable reading.
• No prescription drugs named as longevity treatments in ads or on service pages, and no doses.
• Nothing described as FDA approved for aging or longevity.
• Biological age tests described as estimates, with the lab’s CLIA status confirmed and no claim that a score change means a longer life.
• Prices, membership inclusions, renewal and cancellation terms stated plainly.
• Founder, creator and patient posts carry material connection disclosures, and patient stories have written authorization.
• Intake, lab and booking pages keep health information away from ad tracking tools.
• Prescribing, telehealth and ownership rules confirmed by counsel for each state where you see patients.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses. For a longevity or prevention clinic, that means service pages that describe what the program includes rather than promise more years, search content written around the questions patients ask before they book, and intake forms that keep health information away from tracking tools. We do not decide which treatments a patient should receive or whether a claim is substantiated; your clinicians and counsel do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• 15 U.S.C. 45: Unfair methods of competition and unfair or deceptive acts or practices
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• FDA: Understanding Unapproved Use of Approved Drugs “Off Label” (content current as of February 5, 2018)
• National Institute on Aging: Information on FDA review of geroscience-related IND applications (last updated October 22, 2024)
• CMS: Clinical Laboratory Improvement Amendments (CLIA) (page last modified October 7, 2026)
• 16 CFR 255.2: Consumer endorsements
• 16 CFR 255.5: Disclosure of material connections
• 45 CFR 164.508: Uses and disclosures for which an authorization is required

More in Cash-pay, aesthetic and wellness care